Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Aug 16;5(2):2055116919867178.
doi: 10.1177/2055116919867178. eCollection 2019 Jul-Dec.

Diagnosis and management of a case of retroperitoneal eosinophilic sclerosing fibroplasia in a cat

Affiliations
Case Reports

Diagnosis and management of a case of retroperitoneal eosinophilic sclerosing fibroplasia in a cat

Maureen E Thieme et al. JFMS Open Rep. .

Abstract

Case summary: A 4-year-old neutered male cat was presented with a 2-month history of intermittent constipation that progressed to obstipation. Primary clinical findings included a large, multi lobulated mass in the caudodorsal abdomen, peripheral eosinophilia and hyperglobulinemia. Abdominal imaging revealed a multilobulated, cavitated mass in the sublumbar region. Exploratory celiotomy revealed multiple firm masses in the sublumbar retroperitoneal space causing ventral displacement and compression of the descending colon with extension of the masses into the pelvic canal. Histopathology was consistent with feline gastrointestinal eosinophilic sclerosing fibroplasia (FGESF). Aerobic culture was positive for Staphylococcus aureus. The cat was treated with prednisolone (2 mg/kg PO q24h), lactulose (0.5 g/kg PO q8h), amoxicillin/clavulanic acid (62.5 mg/cat PO q12h for 1 month) and fenbendazole (50 mg/kg PO q24h for 5 days). Six months postoperatively, the cat had no recurrence of clinical signs. Repeat evaluation and imaging at day 732 postoperatively revealed marked improvement of the abdominal mass, resolution of peripheral eosinophilia and no clinical signs with continued prednisolone therapy (0.5 mg/kg PO q24h).

Relevance and novel information: This is a report of a primary extramural FGESF lesion, and the first description of characteristics of FGESF on CT. Previous evidence suggests that the most favorable outcomes require immunosuppressive therapy and complete surgical excision; however, this case demonstrates a favorable outcome with medical management alone.

Keywords: Gastrointestinal; eosinophilic sclerosing fibroplasia; medical; surgery.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1
Figure 1
(a) Right lateral, (b) left lateral and (c) ventrodorsal radiographic projections of the abdomen. The descending colon is ventrally displaced and the urinary bladder is cranially displaced. The colon contains a large amount of heterogeneous feces and gas, and becomes narrowed at the level of the lesion
Figure 2
Figure 2
Examples of a (a) transverse and (b) sagittal slice obtained by abdominal CT. The multilobulated, heterogeneous soft tissue mass (white arrows) present in the caudal abdomen extends into the pelvic canal dorsal to the rectum and urethra and continues caudally just cranial to the anus
Figure 3
Figure 3
Photomicrographs of an excisional biopsy specimen of one of the sublumbar masses in the cat. (a) The well-circumscribed mass consists of sclerotic fibrous tissue with central necrosis. Hematoxylin and eosin stain; bar = 1 mm. (b) Hypertrophied fibroblasts are in the sclerotic tissue and in the scattered foci of eosinophilic inflammation. Hematoxylin and eosin stain; bar = 60 μm. (inset) Higher magnification of an aggregate of eosinophils mixed with other leukocytes and fibroblasts. Hematoxylin and eosin stain; bar = 25 μm
Figure 4
Figure 4
(a) Transverse and (b) sagittal post-contrast abdominal CT images at 732 days postoperatively. There is a single ovoid contrast-enhancing, soft tissue-attenuating mass (white arrows) present within the pelvic canal causing ventral displacement and narrowing of the rectum at the level of the sacrum

References

    1. Craig LE, Hardam EE, Hertzke DMet al. Feline gastrointestinal eosinophilic sclerosing fibroplasia. Vet Pathol 2009; 46: 63–70. - PubMed
    1. Grau-Roma L, Galindo-Cardiel I, Isidoro-Ayza Met al. A case of feline gastrointestinal eosinophilic sclerosing fibroplasia associated with phycomycetes. J Comp Pathol 2014; 151: 318–321. - PubMed
    1. Linton M, Nimmo JS, Norris JMet al. Feline gastrointestinal eosinophilic sclerosing fibroplasia: 13 cases and review of an emerging clinical entity. J Feline Med Surg 2015; 17: 392–404. - PMC - PubMed
    1. Munday J, Martinez A, Soo M. A case of feline gastrointestinal eosinophilic sclerosing fibroplasia mimicking metastatic neoplasia. N Z Vet J 2014; 62: 356–360. - PubMed
    1. Sihvo HK, Simola OT, Vainionpaa MHet al. Pathology in practice. Severe chronic multifocal intramural fibrosing and eosinophilic enteritis, with occasional intralesional bacteria, consistent with feline gastrointestinal eosinophilic sclerosing fibroplasia. J Am Vet Med Assoc 2011; 238: 585–587. - PubMed

Publication types

LinkOut - more resources